Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 25;32(1):10.
doi: 10.1186/s44348-024-00021-6.

2023 Korean Society of Echocardiography position paper for the diagnosis and management of valvular heart disease, part II: mitral and tricuspid valve disease

Chi Young Shim  1 , Eun Kyoung Kim  2 , Dong-Hyuk Cho  3 , Jun-Bean Park  4 , Jeong-Sook Seo  5 , Jung-Woo Son  6 , In-Cheol Kim  7 , Sang-Hyun Lee  8 , Ran Heo  9 , Hyun-Jung Lee  1 , Sahmin Lee  10 , Byung Joo Sun  10 , Se-Jung Yoon  11 , Sun Hwa Lee  12 , Hyung Yoon Kim  13 , Hyue Mee Kim  14 , Jae-Hyeong Park  15 , Geu-Ru Hong  1 , Hae Ok Jung  16 , Yong-Jin Kim  4 , Kye Hun Kim  13 , Duk-Hyun Kang  10 , Jong-Won Ha  1 , Hyungseop Kim  17 ; Korean Valve Survey Investigators
Collaborators, Affiliations
Review

2023 Korean Society of Echocardiography position paper for the diagnosis and management of valvular heart disease, part II: mitral and tricuspid valve disease

Chi Young Shim et al. J Cardiovasc Imaging. .

Abstract

This manuscript represents the official position of the Korean Society of Echocardiography on valvular heart diseases. This position paper focuses on the diagnosis and management of valvular heart diseases with referring to the guidelines recently published by the American College of Cardiology/American Heart Association and the European Society of Cardiology. The committee sought to reflect national data on the topic of valvular heart diseases published to date through a systematic literature search based on validity and relevance. In the part II of this article, we intend to present recommendations for diagnosis and treatment of mitral valve disease and tricuspid valve disease.

Keywords: Mitral regurgitation; Mitral stenosis; Tricuspid regurgitation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Treatment of rheumatic mitral stenosis. AF, atrial fibrillation; LA, left atrium; LAA, left atrial appendage; MDPG, mean diastolic pressure gradient; MR, mitral regurgitation; MVA, mitral valve area; MVR, mitral valve replacement; PASP, pulmonary artery systolic pressure; PMV, percutaneous mitral valvuloplasty; SEC, spontaneous echocontrast
Fig. 2
Fig. 2
Treatment of primary mitral regurgitation (MR). AF, atrial fibrillation; FU, follow-up; LA, left atrium; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; MV, mitral valve; PASP, pulmonary artery systolic pressure; TEER, transcatheter edge-to-edge repair
Fig. 3
Fig. 3
Treatment of secondary mitral regurgitation (MR). CABG, coronary artery bypass graft; ERO, effective regurgitant orifice; HTX, heart transplantation; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; MV, mitral valve; PASP, pulmonary arterial systolic pressure; Reg.V; regurgitant volume; RF, regurgitant fraction; TEER; transcatheter edge-to-edge repair
Fig. 4
Fig. 4
Treatment of tricuspid regurgitation (TR). LV, left ventricle; PH, pulmonary hypertension; RV, right ventricle; TV, tricuspid valve
See this image and copyright information in PMC

References

    1. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;143:e72–227. - PubMed
    1. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561–632. doi: 10.1093/eurheartj/ehab395. - DOI - PubMed
    1. Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N Engl J Med. 2017;377:713–722. doi: 10.1056/NEJMoa1603693. - DOI - PubMed
    1. Jang SY, Ju EY, Seo SR, Choi JY, Park SJ, Kim DK, et al. Changes in the etiology of valvular heart disease in the rapidly aging Korean population. Int J Cardiol. 2014;174:355–359. doi: 10.1016/j.ijcard.2014.04.112. - DOI - PubMed
    1. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984;87:394–402. doi: 10.1016/S0022-5223(19)37390-8. - DOI - PubMed

LinkOut - more resources